| Primary information |
|---|
| sequence ID | Seq_9336 |
| Peptide sequence | VSLGSPSGEVSHPRKT |
| CancerPDF_ID | CancerPDF_ID145, CancerPDF_ID1677, CancerPDF_ID10238, |
| PMID | 17269714,21136997,21805675 |
| Protein Name | Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein |
| UniprotKB Entry Name | FETUA_HUMAN,FETUA_HUMAN,FETUA_HUMAN |
| Fluid | Plasma,Serum,Urine |
| M/Z | NA,1636.85328,1637.8584 |
| Charge | 1,1,NA |
| Mass (in Da) | 1637.88,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | MALDI-TOF,LC-MS,MALDI-TOF |
| Peptide Identification technique | LC-MS/MS,LC-MS-MS/MS,MALDI-TOF-MS |
| Quantification Technique | NA,LC-ESI-MS,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,NA,1 |
| CancerPDF_ID | CancerPDF_ID145, CancerPDF_ID1677, CancerPDF_ID10238, |
| p-Value | NA,NA,NA |
| Software | MASCOT (v 2.1.0),MASCOT(v. 2.2.01),NA |
| Length | 16,16,16 |
| Cancer Type | Normal,Colorectal cancer,Muscle-invasive bladder cancer |
| Database | MSDB Human Database,SwissProt Database,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | NA,30 patients and 30 healthy controls,751 bladder cancer and 127 control |
| Regulation | NA,NA,Differentially expressed between cancer vs normal samples |
| Validation | NA,Leave One out Cross validation,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |